Giant Cell Arteritis and Polymyalgia Rheumatica: an Update

被引：48

作者：

Gonzalez-Gay, Miguel A. ^{[1
,2
]}

Pina, Trinitario ^{[1
]}

机构：

[1] Hosp Univ Marques Valdecilla, IDIVAL, Div Rheumatol, Epidemiol Genet & Atherosclerosis Res Grp Syst In, Santander 39008, Spain

[2] Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Cardiovasc Pathophysiol & Genom Res Unit, Johannesburg, South Africa

来源：

CURRENT RHEUMATOLOGY REPORTS | 2015年 / 17卷 / 02期

关键词：

Giant cell arteritis; Polymyalgia rheumatica; Aortitis; FDG-PET; Treatment; LARGE-VESSEL VASCULITIS; PRESENTING MANIFESTATION; NORTHWESTERN SPAIN; DIAGNOSIS; AORTITIS; ULTRASONOGRAPHY; SUSCEPTIBILITY; EPIDEMIOLOGY; TOCILIZUMAB; INVOLVEMENT;

D O I：

10.1007/s11926-014-0480-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are two closely related diseases in people aged 50 years and older, which are more frequently observed in Western countries. Despite being common entities, concern still exists about the epidemiology, pathogenesis, and diagnosis of both entities. New imaging techniques, such as 18 fluorodeoxyglucose-positron emission tomography, have proved to be useful in detecting large-vessel involvement in GCA. Corticosteroids are the cornerstone of the therapy in GCA and PMR. Relapses are frequent in these conditions. Unlike methotrexate and tumor necrosis factor-a antagonists, anti-interleukin-6 receptor therapy appears to be useful in patients with GCA and PMR who are refractory to corticosteroids. This review summarizes recent studies on GCA and PMR.

引用

页数：7

共 52 条

[1] Relapses in Patients With Giant Cell Arteritis Prevalence, Characteristics, and Associated Clinical Findings in a Longitudinally Followed Cohort of 106 Patients [J].

Alba, Marco A. ;

Garcia-Martinez, Ana ;

Prieto-Gonzalez, Sergio ;

Tavera-Bahillo, Itziar ;

Corbera-Bellalta, Marc ;

Planas-Rigol, Ester ;

Espigol-Frigole, Georgina ;

Butjosa, Montserrat ;

Hernandez-Rodriguez, Jose ;

Cid, Maria C. .

MEDICINE, 2014, 93 (05) :194-201

[2] Giant Cell Arteritis in Mexican Patients [J].

Alba, Marco A. ;

Mena-Madrazo, Jorge A. ;

Reyes, Edgardo ;

Felipe Flores-Suarez, Luis .

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2012, 18 (01) :1-7

[3] The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis [J].

Arida, Aikaterini ;

Kyprianou, Miltiades ;

Kanakis, Meletios ;

Sfikakis, Petros P. .

BMC MUSCULOSKELETAL DISORDERS, 2010, 11

[4] Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumaticae [J].

Baerlecken, N. T. ;

Linnemann, A. ;

Gross, W. L. ;

Moosig, F. ;

Vazquez-Rodriguez, T. R. ;

Gonzalez-Gay, M. A. ;

Martin, J. ;

Koetter, I ;

Henes, J. C. ;

Melchers, I ;

Vaith, P. ;

Schmidt, R. E. ;

Witte, T. .

ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (06) :943-947

[5]

Bejerano C, 2012, CLIN EXP RHEUMATOL, V30, pS110

[6]

Bejerano C, 2012, CLIN EXP RHEUMATOL, V30, pS94

[7]

Cavazza A, 2014, AM J SURG PATHOL, V38, P1360, DOI 10.1097/PAS.0000000000000244

[8] Genetic component of giant cell arteritis [J].

David Carmona, F. ;

Gonzalez-Gay, Miguel A. ;

Martin, Javier .

RHEUMATOLOGY, 2014, 53 (01) :6-18

[9] NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica [J].

Dejaco, Christian ;

Duftner, Christina ;

Al-Massad, Juman ;

Wagner, Annette D. ;

Park, Joon-Keun ;

Fessler, Johannes ;

Aigelsreiter, Ariane ;

Hafner, Franz ;

Vega, Sandra ;

Sterlacci, William ;

Grubeck-Loebenstein, Beatrix ;

Tzankov, Alexander ;

Ness, Thomas ;

Boiardi, Luigi ;

Salvarani, Carlo ;

Schirmer, Michael .

ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (11) :1852-1859

[10] Leflunomide as a Corticosteroid-Sparing Agent in Giant Cell Arteritis and Polymyalgia Rheumatica: A Case Series [J].

Diamantopoulos, Andreas P. ;

Hetland, Helene ;

Myklebust, Geirmund .

BIOMED RESEARCH INTERNATIONAL, 2013, 2013

← 1 2 3 4 5 6 →